Your browser doesn't support javascript.
loading
Implementation, feasibility, and acceptability of 99DOTS-based supervision of treatment for drug-susceptible TB in Uganda.
Kiwanuka, Noah; Kityamuwesi, Alex; Crowder, Rebecca; Guzman, Kevin; Berger, Christopher A; Lamunu, Maureen; Namale, Catherine; Kunihira Tinka, Lynn; Nakate, Agnes Sanyu; Ggita, Joseph; Turimumahoro, Patricia; Babirye, Diana; Oyuku, Denis; Patel, Devika; Sammann, Amanda; Turyahabwe, Stavia; Dowdy, David W; Katamba, Achilles; Cattamanchi, Adithya.
Afiliação
  • Kiwanuka N; Department of Epidemiology & Biostatistics, School of Public Health, College of Health Sciences, Makerere University, Kampala, Uganda.
  • Kityamuwesi A; Walimu, Uganda Tuberculosis Implementation Research Consortium, Kampala, Uganda.
  • Crowder R; Center for Tuberculosis and Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America.
  • Guzman K; Department of Medicine, University of California San Francisco, San Francisco, California, United States.
  • Berger CA; Center for Tuberculosis and Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America.
  • Lamunu M; Walimu, Uganda Tuberculosis Implementation Research Consortium, Kampala, Uganda.
  • Namale C; Walimu, Uganda Tuberculosis Implementation Research Consortium, Kampala, Uganda.
  • Kunihira Tinka L; Walimu, Uganda Tuberculosis Implementation Research Consortium, Kampala, Uganda.
  • Nakate AS; Walimu, Uganda Tuberculosis Implementation Research Consortium, Kampala, Uganda.
  • Ggita J; Walimu, Uganda Tuberculosis Implementation Research Consortium, Kampala, Uganda.
  • Turimumahoro P; Walimu, Uganda Tuberculosis Implementation Research Consortium, Kampala, Uganda.
  • Babirye D; Walimu, Uganda Tuberculosis Implementation Research Consortium, Kampala, Uganda.
  • Oyuku D; Walimu, Uganda Tuberculosis Implementation Research Consortium, Kampala, Uganda.
  • Patel D; Department of Surgery, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America.
  • Sammann A; Department of Surgery, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America.
  • Turyahabwe S; Uganda National Tuberculosis and Leprosy Programme, Ministry of Health, Kampala, Uganda.
  • Dowdy DW; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
  • Katamba A; Walimu, Uganda Tuberculosis Implementation Research Consortium, Kampala, Uganda.
  • Cattamanchi A; Department of Medicine, School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda.
PLOS Digit Health ; 2(6): e0000138, 2023 Jun.
Article em En | MEDLINE | ID: mdl-37390077
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article